The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.109.11.866

U 500 insulin did not induce therapeutic comas more readily than other conventional concentrations of insulin. The time required for the development of the therapeutic coma was not altered by the use of U 500. Delayed insulin reactions were not more frequent with U 500 insulin than with other types provided the total dosage was equivalent. No untoward clinical effects were noted when U 500 was employed. U 500 insulin can be recommended for deep insulin coma in the treatment of mentally ill patients.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.